Glypentide: a new hypoglycaemic agent.
D000284:Administration, Oral; D000818:Animals; D001549:Benzamides / Q000494:pharmacology / Q000633:toxicity; D001786:Blood Glucose; D003517:Cyclopentanes / Q000494:pharmacology / Q000633:toxicity; D004285:Dogs; D006168:Guinea Pigs; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D007275:Injections, Intravenous; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007928:Lethal Dose 50; D051379:Mice; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D013997:Time Factors
D001549:Benzamides; D001786:Blood Glucose; D003517:Cyclopentanes; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds